These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 25483461
1. Sero-surveillance to assess rubella susceptibility and assessment of immunogenicity and reactogenicity of rubella vaccine in Indian girls aged 18-24 years. Phalgune DS, Yervadekar RC, Sharma HJ, Dhere RM, Parekh SS, Chandak AO, Safai AA, Shewale SD. Hum Vaccin Immunother; 2014; 10(10):2813-8. PubMed ID: 25483461 [Abstract] [Full Text] [Related]
2. Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India. Sharma HJ, Padbidri VS, Kapre SV, Jadhav SS, Dhere RM, Parekh SS, Dudhane AD, Shewale SD, Namjoshi GS. J Infect Dev Ctries; 2011 Dec 13; 5(12):874-81. PubMed ID: 22169787 [Abstract] [Full Text] [Related]
3. Sero-Surveillance to Assess Immunity to Rubella and Assessment of Immunogenicity and Safety of a Single dose of Rubella Vaccine in School Girls. Sharma H, Chowdhari S, Raina TR, Bhardwaj S, Namjoshi G, Parekh S. Indian J Community Med; 2010 Jan 13; 35(1):134-7. PubMed ID: 20606938 [Abstract] [Full Text] [Related]
5. Rubella virus immunization status in preconception period among Chinese women of reproductive age: A nation-wide, cross-sectional study. Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, Acharya G. Vaccine; 2017 May 25; 35(23):3076-3081. PubMed ID: 28456531 [Abstract] [Full Text] [Related]
6. Enhanced surveillance for congenital rubella syndrome following mass rubella vaccination of girls and reproductive-aged women. Villagra E, Delgado LV, Olea A. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S642-6. PubMed ID: 21954260 [Abstract] [Full Text] [Related]
7. Seroprevalence of rubella among Jordanian women of childbearing age. Jarour N, Hayajneh WA, Balbeesi A, Otoom H, Al-Shurman A, Kharabsheh S. Vaccine; 2007 May 04; 25(18):3615-8. PubMed ID: 17280747 [Abstract] [Full Text] [Related]
8. Rubella vaccine: new horizon in prevention of congenital rubella syndrome in the India. Verma R, Khanna P, Chawla S. Hum Vaccin Immunother; 2012 Jun 04; 8(6):831-3. PubMed ID: 22495120 [Abstract] [Full Text] [Related]
13. [Phases 3 and 4 immunization immunogenicity with combined measles-rubella vaccine]. Ozaki T, Nishimura N, Gotoh K, Ohe K, Funahashi K, Maeda K, Okuno Y. Kansenshogaku Zasshi; 2011 May 04; 85(3):250-5. PubMed ID: 21706844 [Abstract] [Full Text] [Related]
14. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran. Soleimanjahi H, Bamdad T, Fotouhi F, Roustai MH, Faghihzadeh S. J Clin Virol; 2005 Oct 04; 34(2):153-4. PubMed ID: 16076562 [Abstract] [Full Text] [Related]
16. Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study. Abu-Elyazeed R, Jennings W, Severance R, Noss M, Caplanusi A, Povey M, Henry O. Hum Vaccin Immunother; 2018 Oct 04; 14(11):2624-2631. PubMed ID: 29902133 [Abstract] [Full Text] [Related]
18. [Effectiveness of rubella vaccination in the puerperium]. Huter O, Ortner A. Geburtshilfe Frauenheilkd; 1986 Sep 04; 46(9):640-2. PubMed ID: 3770413 [Abstract] [Full Text] [Related]